[{"AccountsPayableCurrent_0_Q1_USD":4434000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":2121000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":2010000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":1081000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":2121000.0,"OtherLiabilitiesCurrent_0_Q1_USD":133000.0,"IncreaseDecreaseInOtherOperatingAssets_1_Q1_USD":215000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":109637000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q1_USD":-11324000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":17520000.0,"DepreciationDepletionAndAmortization_1_Q1_USD":305000.0,"DeferredRevenueCurrent_0_Q1_USD":6047000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-13508000.0,"OtherAssetsNoncurrent_0_Q1_USD":1874000.0,"NonoperatingIncomeExpense_1_Q1_USD":212000.0,"FairValueAdjustmentOfWarrants_1_Q1_USD":0.0,"ClassOfWarrantOrRightOutstanding_0_Q1_shares":50000.0,"AccruedProfessionalFeesCurrent_0_Q1_USD":717000.0,"PropertyPlantAndEquipmentGross_0_Q1_USD":5025000.0,"IncreaseDecreaseInDeferredRevenue_1_Q1_USD":30103000.0,"ContractWithCustomerLiability_0_Q1_USD":34253000.0,"ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress_1_Q1_USD":-1275000.0,"ContractWithCustomerLiabilityRevenueRecognized_1_Q1_USD":1129000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1_Q1_USD":-2184000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q1_pure":0.0856,"OperatingLeaseRightOfUseAsset_0_Q1_USD":1815000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":1056000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":636000.0,"OperatingLeaseCost_1_Q1_USD":223000.0,"NumberOfOperatingSegments_1_Q1_segment":2.0,"NoncurrentAssets_0_Q1_USD":4018000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q1_USD":245000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q1_USD":743000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q1_USD":751000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q1_USD":443000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q1_USD":1692000.0,"LeaseCost_1_Q1_USD":362000.0,"IncreaseDecreaseInOtherNoncurrentLiabilities_1_Q1_USD":152000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_1_Q1_USD":-464000.0,"ForeignCurrencyTransactionGainLossRealized_1_Q1_USD":1300000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1_Q1_USD":-3324000.0,"DeferredRevenueNoncurrent_0_Q1_USD":28206000.0,"InterestAndOtherIncome_1_Q1_USD":212000.0,"Cash_0_Q1_USD":109637000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q1_USD":2822000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":2000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":-347000.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":846000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":2702000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":-107000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q1_USD":-11431000.0,"GeneralAndAdministrativeExpense_1_Q1_USD":4998000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-0.63,"Depreciation_1_Q1_USD":300000.0,"CommonStockValue_0_Q1_USD":227000.0,"CommonStockSharesOutstanding_0_Q1_shares":18016207.0,"CommonStockSharesIssued_0_Q1_shares":18016207.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":0.0,"AssetsCurrent_0_Q1_USD":123390000.0,"Assets_0_Q1_USD":129282000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":3726338.0,"AdditionalPaidInCapital_0_Q1_USD":197179000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":-3719000.0,"AccruedIncomeTaxesCurrent_0_Q1_USD":7000.0,"AccountsReceivableNetCurrent_0_Q1_USD":1002000.0,"Liabilities_0_Q1_USD":47469000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":1129000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":129282000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":2000.0,"ShareBasedCompensation_1_Q1_USD":2121000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":7774000.0,"OperatingIncomeLoss_1_Q1_USD":-11643000.0,"OperatingExpenses_1_Q1_USD":12772000.0,"IncomeTaxesPaidNet_1_Q1_USD":11000.0,"CommonStockSharesAuthorized_0_Q1_shares":31995653.0,"CommonStockParOrStatedValuePerShare_0_Q1_GBP":0.01,"CommitmentsAndContingencies_0_Q1_USD":null,"AccruedLiabilitiesCurrent_0_Q1_USD":5716000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":17997929.0,"StockholdersEquity_0_Q1_USD":81813000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-111874000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":2203000.0,"ProfitLoss_1_Q1_USD":-11324000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":4248000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":320000.0,"NetIncomeLoss_1_Q1_USD":-11324000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":21162000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-320000.0,"LiabilitiesCurrent_0_Q1_USD":16197000.0,"VariableLeaseCost_1_Q1_USD":139000.0,"Ticker":"BCYC","CIK":"1761612","name":"BICYCLE THERAPEUTICS PLC","OfficialName":"Bicycle Therapeutics plc American Depositary Shares","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"738781455.0","Country":"United Kingdom","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200507"}]